secwatch / observer
8-K filed November 19, 2024, 6:59 PM ET ticker CDT CIK 0001896212
leadership confidence high sentiment neutral materiality 0.45

Conduit Pharma appoints director Fry (420K options); amends CFO pay (£400K, 40% bonus) and quorum rule

CDT Equity Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Simon Fry

director
CDT · CDT Equity Inc.
Effective
2024-12-18
Filed
November 19, 2024, 6:59 PM ET
the Board of Directors (the “Board”) of Conduit Pharmaceuticals Inc. (the “Company”) appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Simon Fry was appointed as director at CDT Equity Inc..

Action
appointed
Role
director
Exact text from the filing
the Board of Directors (the “Board”) of Conduit Pharmaceuticals Inc. (the “Company”) appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

CDT Equity Inc.: Amended Section 2.4 of the Bylaws to reduce the quorum requirement for stockholder meetings from a majority to at least one-third of voting power outstanding and entitled to vote.

Change
bylaw amendment
Exact text from the filing
The Amendment amends Section 2.4 of the Bylaws, dealing with a quorum at meetings of stockholders, to generally provide that a quorum is at least one-third of the voting power of the stock outstanding and entitled to vote at the meeting, present in person or represented by proxy.
View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

CDT Equity Inc. filing history →

Source: SEC EDGAR
accession 0001493152-24-046849
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.